Chinese women aged 65 years or older have significantly higher rates of high-risk human papillomavirus infection and cervical ...

Women 65 and older face significantly higher rates of cervical cancer-causing HPV infections than younger women, despite current medical guidelines that typically discontinue screening at 65. The ...

Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the ...

Even with all this research readily available, some doctors still say many women over 65 don’t need Pap smears, including ...

Women aged 65 and above are still at heightened risk of cervical cancer caused by human papillomavirus (HPV), suggest the findings of a large observational study published in the open access journal ...

For almost 30 years, states have received money from the National Breast and Cervical Cancer Early Detection Program, which ...

State workers who for decades have been pivotal in identifying U.S. cancer trends, curbing new cases, and improving screening ...

On Friday, a San Francisco-based startup received FDA approval for the first-ever at-home cervical cancer test. The company, named Teal Health, was founded in 2020 and has raised $23 million.

At-home cervical cancer screening test gets FDA approval. How it works, availability The Teal Wand is an at-home vaginal sample self-collection device that tests for HPV.

The research is just the beginning of uncovering how S. haematobium could play a role in cervical cancer. A larger study tracking 180 women over 12 months is already underway to confirm the findings.

Cervical cancer starts in the cells of the cervix, which connects the uterus and vagina. It is slow to develop, quietly growing for months or even years before it’s diagnosed.